GC Wellbeing Corp

GC Wellbeing Corp has a debt-to-equity ratio of 0.67, indicating a moderate level of leverage, and a current ratio of 1.13, suggesting limited short-term liquidity cushion. The company's free cash flow of 7.68 billion KRW and operating cash flow of 5.73 billion KRW reflect positive cash generation, but its net cash position is negative after subtracting total debt. The company's return on equity (ROE) of 8.88% and return on assets (ROA) of 4.5% are below the industry median for Food Processing, which typically sees ROE in the 10-12% range and ROA in the 5-6% range. This suggests that GC Wellbeing Corp is underperforming in terms of capital efficiency and asset utilization. According to disclosed segments, GC Wellbeing Corp's revenue is concentrated in injections and health functional foods, with a smaller portion from cosmetics. The company's Dr.PNT brand is used for health functional foods sold in hospitals, but no specific geographic breakdown is provided in the input data. The company's revenue growth is expected to accelerate from the current fiscal year to the next, with analysts forecasting a mean revenue estimate of 201.2 billion KRW compared to the actual 164.68 billion KRW. However, the operating income and EBIT estimates are also higher than actuals, indicating potential volatility in cost control and profitability. The risk assessment highlights medium liquidity risk and low dilution risk, but the key flag of negative net cash after debt is a concern. The company has not issued additional shares recently, and no dilution sources are identified in the input data. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's capital expenditure of -6.196 billion KRW suggests a reduction in investment, which may impact long-term growth.